1. Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia. (30th May 2019) Authors: Aydinok, Yesim; Piga, Antonio; Origa, Raffaella; Mufti, Nina; Erickson, Anna; North, Anne; Waldhaus, Katie; Ernst, Christine; Lin, Jin‐Sying; Huang, Norman; Benjamin, Richard J.; Corash, Laurence Journal: British journal of haematology Issue: Volume 186:Number 4(2019) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Approaching low liver iron burden in chelated patients with non‐transfusion‐dependent thalassemia: the safety profile of deferasirox. (25th March 2014) Authors: Taher, Ali T.; Porter, John B.; Viprakasit, Vip; Kattamis, Antonis; Chuncharunee, Suporn; Sutcharitchan, Pranee; Siritanaratkul, Noppadol; Origa, Raffaella; Karakas, Zeynep; Habr, Dany; Zhu, Zewen; Cappellini, M. Domenica Journal: European journal of haematology Issue: Volume 92:Number 6(2014:Jun.) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crushed deferasirox film‐coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single‐arm, interventional phase 4 study (MIMAS). Issue 8 (31st May 2022) Authors: Wali, Yasser; Hassan, Tamer; Charoenkwan, Pimlak; Trompeter, Sara; Tartaglione, Immacolata; Origa, Raffaella; Gamberini, Maria Rita; Viprakasit, Vip; Izquierdo, Miguel; Opio, Socrates; Roy, Tania; Taher, Ali Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: E292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deferasirox and children: From clinical trials to the real world. Issue 6 (13th April 2016) Authors: Origa, Raffaella; Zappu, Antonietta; Foschini, Maria Loreta; Leoni, Giovanbattista; Morittu, Maddalena; Moi, Paolo; Corpino, Mara; Dessì, Carlo Journal: American journal of hematology Issue: Volume 91:Issue 6(2016:Jun.) Page Start: E304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deferasirox for cardiac siderosis in β‐thalassaemia major: a multicentre, open label, prospective study. (30th June 2014) Authors: Piga, Antonio; Longo, Filomena; Origa, Raffaella; Roggero, Simona; Pinna, Francesca; Zappu, Antonietta; Castiglioni, Chiara; Cappellini, Maria Domenica Journal: British journal of haematology Issue: Volume 167:Number 3(2014:Nov.) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non‐transfusion‐dependent thalassaemia. (12th September 2014) Authors: Taher, Ali T.; Porter, John B.; Viprakasit, Vip; Kattamis, Antonis; Chuncharunee, Suporn; Sutcharitchan, Pranee; Siritanaratkul, Noppadol; Origa, Raffaella; Karakas, Zeynep; Habr, Dany; Zhu, Zewen; Cappellini, Maria Domenica Journal: British journal of haematology Issue: Volume 168:Number 2(2015:Jan.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion‐dependent thalassemia. Issue 11 (25th September 2017) Authors: Origa, Raffaella; Tatti, Federica; Zappu, Antonietta; Leoni, Giovan Battista; Dessì, Carlo; Moi, Paolo; Morittu, Maddalena; Orecchia, Valeria; Denotti, Anna Rita; Pilia, Maria Paola; Anni, Franco; Perra, Maria; Casini, Maria Rosaria; Barella, Susanna Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: E627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations. Issue 3 (11th February 2017) Authors: Schotten, Nienke; Laarakkers, Coby M. M.; Roelofs, Rian W.; Origa, Raffaella; van Kraaij, Marian G. J.; Swinkels, Dorine W. Journal: American journal of hematology Issue: Volume 92:Issue 3(2017:Mar.) Page Start: E29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations. Issue 3 (March 2017) Authors: Schotten, Nienke; Laarakkers, Coby M. M.; Roelofs, Rian W.; Origa, Raffaella; van Kraaij, Marian G. J.; Swinkels, Dorine W. Journal: American journal of hematology Issue: Volume 92:Issue 3(2017:Mar.) Page Start: E29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Issue 6 (June 2020) Authors: Maggio, Aurelio; Kattamis, Antonis; Felisi, Mariagrazia; Reggiardo, Giorgio; El-Beshlawy, Amal; Bejaoui, Mohamed; Sherief, Laila; Christou, Soteroula; Cosmi, Carlo; Della Pasqua, Oscar; Del Vecchio, Giovanni Carlo; Filosa, Aldo; Cuccia, Liana; Hassab, Hoda; Kreka, Manika; Origa, Raffaella; Putti,... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗